The global CRRT market is anticipated to grow significantly at a CAGR of 5.8% over the forecast period. The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. For an instance, in 2020, Medtronic PLC announced the launch of the Carpediem system, the first and only pediatric and neonatal acute dialysis system designed to treat patients weighing 2.5–10 kg (5.5–22 pounds) requiring renal replacement therapy. In addition, in 2019, Baxter International Inc. introduced the PrisMax CRRT system in the US. Further, in 2019, Fresenius Medical Care AG & CO. KGaA announced the launch of the 4008A dialysis machine in India. Such activities are likely to aid the company’s growth as well as the growth of the global CRRT market during the forecast period.
Browse the full report description of “Global Continuous Renal Replacement Therapy (CRRT) Market Size, Share & Trends Analysis Report by Product (Dialysates and Replacement Fluids and Disposables), by Modality (Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodiafiltration (CVVHDF), Continuous Venovenous Hemodialysis (CVVHD), Slow Continuous Ultrafiltration (SCUF)), and by Age-Group (Adults and Pediatrics /Neonates) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/crrt-market
Apart from this, the market is segmented into product, modality, and age group. Among the age group, the adult segment is expected to grow at a significant rate during the forecast period. The attributable factor for the growth of the segment is the increasing geriatric population. The world is currently on the edge of achieving a demographic milestone. In earlier decades, the population aging less than 5 years was more as compared to the number of people aged 65 or above. However, in the current scenario, the situation is completely different. This change is driven by falling fertility rates and a noteworthy rise in the life expectancy rate. The aging population is anticipated to grow continuously, at a uniform rate in the next 10 years. For instance, according to the World Health Organization (WHO), the number of people aged 60 years or above was around 900 million in 2015 and it is estimated to reach nearly 2.0 billion in 2050, with most of the increase in the developing countries. The proportion of the population of age 60 years or above between 2015 to 2050 will get doubled from 12% to 22%. By 2050, 80% of the globally elderly would live in low- and middle-income countries. The population is aging at a considerably higher rate than in the past.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered- by Product, Modality, and Age-Group.
• Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
• Competitive Landscape- Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, NIKKISO CO., LTD., B. Braun Melsungen AG among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global CRRT Market – Segmentation
By Product
By Modality
By Age-Group
Global CRRT Market – Segmentation by Region
North America
• US
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/crrt-market